5-Methoxytryptophan alleviates atrial structural remodeling in ibrutinib-associated atrial fibrillation

BACKGROUND: Ibrutinib is an effective and well-tolerated treatment for B-cell lymphomas but is associated with an increased risk of atrial fibrillation (AF) by altering the structure of the atrium. 5-Methoxytryptophan (5-MTP) inhibits inflammatory and fibrotic processes. This study aimed to determin...

Descripción completa

Detalles Bibliográficos
Autores principales: Shuai, Wei, Peng, Bo, Zhu, Jun, Kong, Bin, Fu, Hui, Huang, He
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558721/
https://www.ncbi.nlm.nih.gov/pubmed/37810107
http://dx.doi.org/10.1016/j.heliyon.2023.e19501

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558721/
https://www.ncbi.nlm.nih.gov/pubmed/37810107
http://dx.doi.org/10.1016/j.heliyon.2023.e19501

Ejemplares similares